Lorena has been with Charles River since 2019 – first as a flow cytometry manager and now in her current role as Group Leader of in vitro biology, where her work mainly focuses on both small- and large-molecule drug candidates. Her role is to design and execute assays that help identify novel therapeutics in oncology and autoimmune disease. Lorena studied immunology at the University of Barcelona and went on to earn an MRes in immuno-oncology from the University of Bristol (UoB), where she investigated the role of co-inhibitory receptor blockades in renal carcinoma. Following her postgraduate studies, she became a flow cytometry specialist at UoB’s core facility, supporting researchers with experimental design and assay development.
Target Smarter: Translational Tools for Immune Reset in Autoimmune and Allergy Therapeutics
This webinar will explore how CAR-T, B cell-depleting therapies, and mast cell-targeted approaches are reshaping the future of treatment and, more importantly, how it will influence your drug discovery strategies. Whether you’re advancing a new candidate or exploring drug repurposing opportunities, this session delivers insights to help you stay ahead and drive the future of immunology drug discovery. Watch Replay